申请人:GLAXOSMITHKLINE LLC
公开号:WO2012037351A1
公开(公告)日:2012-03-22
Compounds, pharmaceutical compositions containing them, and their use treatment of conditions mediated by the TRPC3 and/or TRPC6 ion channels.
化合物,含有它们的制药组合物,以及它们用于治疗由TRPC3和/或TRPC6离子通道介导的疾病的用途。